SMAD2 and postmenopausal osteoporosis: It is worth mentioning that regulation of the TGF‐β/Smad2/COL4A1 signaling pathway promotes osteogenic differentiation of bone marrow stromal cells and is of great significance for the new treatments strategy for postmenopausal osteoporosis [32].